Summary
CHICAGO, Aug. 17, 2011 /PRNewswire-USNewswire/ -- Women's Health Foundation (WHF), in collaboration with the Association for Pelvic Organ Prolapse Support (APOPS) announced today that they will be representing female patients' stories who have undergone transvaginal mesh surgical treatment for pelvic organ prolapse at an upcoming FDA meeting in Washington, D.C. This meeting is in response to the FDA's recent public health notification warning regarding the safety of transvaginal mesh.
Pelvic organ prolapse is when one or more of the pelvic organs including the uterus, vagina, bladder, or rectum, fall down or slip out place. Twenty to 30 percent of women suffer from some degree of prolapse, according to estimates from Brigham & Women's Hospital. Approximately 300,000 women undergo surgery each year for pelvic organ prolapse in the United States, according to the American Urogynecological Society.See the full content of this document
Extract
Hearing
In 2008, the FDA first released concerns about the safety of transvaginal placement of mesh. From 2008 to 2010, the FDA received five times as many adver...
See the full content of this document
Sponsored links
